Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019

SELL
$281.08 - $444.25 $6.69 Million - $10.6 Million
-23,800 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$354.53 - $449.75 $4.55 Million - $5.78 Million
-12,846 Reduced 35.05%
23,800 $10.7 Million
Q2 2018

Aug 14, 2018

SELL
$278.07 - $446.21 $82.3 Million - $132 Million
-295,803 Reduced 88.98%
36,646 $15 Million
Q1 2018

May 15, 2018

BUY
$192.49 - $295.85 $22.6 Million - $34.7 Million
117,449 Added 54.63%
332,449 $96.7 Million
Q4 2017

Feb 14, 2018

BUY
$168.78 - $199.74 $27.6 Million - $32.6 Million
163,271 Added 315.63%
215,000 $40.3 Million
Q3 2017

Nov 14, 2017

BUY
$145.39 - $168.6 $7.52 Million - $8.72 Million
51,729
51,729 $8.72 Million

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.